As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  4/2/21  Arduini Peter J                   4          Director²   1:5K   Bristol-Myers Squibb Co.          Bristol-Myers Squibb Co. 
  4/2/21  Bertolini Robert J                4          Director²   1:5K   Bristol-Myers Squibb Co.          Bristol-Myers Squibb Co. 
  4/2/21  Bonney Michael W                  4          Director²   1:5K   Bristol-Myers Squibb Co.          Bristol-Myers Squibb Co. 
  4/2/21  Emmens Matthew                    4          Director²   1:5K   Bristol-Myers Squibb Co.          Bristol-Myers Squibb Co. 
  4/2/21  Haller Julia A                    4          Director²   1:5K   Bristol-Myers Squibb Co.          Bristol-Myers Squibb Co. 
  4/2/21  Mily Elizabeth                    4          Officer²    1:11K  Bristol-Myers Squibb Co.          Bristol-Myers Squibb Co. 
  4/2/21  Paliwal Dinesh C                  4          Director²   1:5K   Bristol-Myers Squibb Co.          Bristol-Myers Squibb Co. 
  4/2/21  Price Paula A                     4          Director²   1:5K   Bristol-Myers Squibb Co.          Bristol-Myers Squibb Co. 
  4/2/21  Rice Derica W                     4          Director²   1:5K   Bristol-Myers Squibb Co.          Bristol-Myers Squibb Co. 
  4/2/21  Samuels Theodore R. II            4          Director²   1:5K   Bristol-Myers Squibb Co.          Bristol-Myers Squibb Co. 
  4/2/21  Storch Gerald L                   4          Director²   1:5K   Bristol-Myers Squibb Co.          Bristol-Myers Squibb Co. 
  4/2/21  Yale Phyllis R                    4          Director²   1:5K   Bristol-Myers Squibb Co.          Bristol-Myers Squibb Co. 

____________
¹	Filing/Form Type:  -K
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.